| 本文已被：浏览 2469次 下载 2895次 |
码上扫一扫！ |
| 转谷氨酰胺酶4在前列腺癌组织中的表达及意义 |
| 李磊1△,曹智1△,许传亮1,韦荣超1,张振声1,余永伟2,王洋2,孙颖浩1* |
|
|
(1. 第二军医大学长海医院泌尿外科, 上海 200433;
2. 第二军医大学长海医院病理科, 上海 200433
△共同第一作者
*通信作者) |
|
| 摘要: |
| 目的 探讨转谷氨酰胺酶4（transglutaminase 4， TGM4）在前列腺癌诊断及预后评价中的可能价值。 方法 对159例前列腺癌患者的存档石蜡标本行TGM4免疫组织化学染色；根据染色情况将TGM4表达水平分为4级：不表达，弱表达，中表达和高表达。通过查阅病历、调用我院前列腺癌随访数据库和电话随访等方式获得患者临床病理资料及随访信息；进而对TGM4表达水平与前列腺癌临床病理特征及预后信息的关系进行统计学分析。 结果 与癌旁组织相比，TGM4在前列腺癌组织中高表达（P<0.001），且表达水平在不同Gleason分级（P<0.001）和前列腺特异抗原（PSA）水平（P=0.005）间差异有统计学意义。单因素Cox回归分析提示TGM4高表达是前列腺癌生化复发的高危因素（P=0.020），但多因素Cox回归分析并不支持TGM4高表达是前列腺癌生化复发的高危因素（P=0.139）。 结论 TGM4在前列腺癌中高表达，且在高Gleason分级和高PSA水平的前列腺癌中表达更高，值得进一步研究。 |
| 关键词: 前列腺肿瘤 免疫组织化学染色 转谷氨酰胺酶4 生化复发 |
| DOI：10.3724/SP.J.1008.2014.00734 |
| 投稿时间：2013-10-27修订日期：2014-01-09 |
| 基金项目: |
|
| Expression of transglutaminase 4 in prostate cancer and its clinical significance |
| LI Lei1△,CAO Zhi1△,XU Chuan-liang1,WEI Rong-chao1,ZHANG Zhen-sheng1,YU Yong-wei2,WANG Yang2,SUN Ying-hao1* |
(1. Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China;
2. Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
△Co-first authors.
* Corresponding author.) |
| Abstract: |
| Objective To investigate the value of transglutaminase 4 in diagnosis and prognosis prediction of prostate cancer. Methods Transglutaminase 4 immunostaining was performed with paraffin sections from 159 prostate cancer patients receiving radical prostatectomy, and the staining results were divided into 4 levels: negative staining, weak staining, moderate staining, and strong staining. The clinical and pathological information of the patients were obtained by reviewing the medical records. The follow-up data were collected by reviewing medical records, prostate cancer database of our department, and telephoning the patients or their family members. Expression of transglutaminase 4 and clinical, prognosis data of patients were subjected to statistical analysis. Results The expression of transglutaminase 4 in the prostatic cancer tissue was significantly higher than that in the adjacent normal tissue (P<0.001); and the expressions were significantly different in patients with different Gleason grades (P<0.001) and different prostate specific antigen levels(P=0.005). Univariate Cox regression analysis indicated that high transglutaminase 4 expression was a risk factor of biochemical recurrence of prostatic cancer (P=0.020), but multivariate Cox regression analysis did not support this finding (P=0.139). Conclusion Transglutaminase 4 expression is increased in prostate cancer tissues, and the expression is stronger in malignant tissues with higher Gleason grade and prostate specific antigen level. |
| Key words: prostatic neoplasms immunohistochemistry transglutaminase 4 biochemical recurrence |
